KLRK1 and neoplasm: HDAC inhibitors have been reported to upregulate expression of NKG2D ligands, and enhance NK cell-mediated killing by regulating immune-related genes and chemokines responsible for the increased infiltration of NK cells into tumor tissues (11, 26, 27).